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Introduction
Clostridium difficile (CD) is an anaerobic, spore-forming, Gram-
positive bacterium producing cytotoxic toxins, recognized in the 1970 
as the cause of antibiotic-associated pseudomembranous colitis [1]. CD 
infection (CDI) is a major cause of hospital-acquired diarrhea. Despite 
the great efforts working in the ambit, infections increased in incidence 
and severity over the past decade and the management became more 
daunting, causing significant escalation of the related health-care 
economic burden [2]. The specific antibacterial treatment implies 
significant and increasing failures, recurring infections and additional 
modifications of microbial intestinal consortium of treated patients [3]. 
Prevention of CDI should be essential, but current deficit of knowledge 
limits the chances to advance in effective preventive measure. These 
limitations are due to complex CD pathogenicity, mostly concerning 
the health care CD acquisition and the reasons allowing the shift from 
bacterial intestinal presence to the infectious disease [2].
It is now ascertained that CDI is most commonly connected to 
increased age of patients and to changes in normal intestinal biota, the 
latter most due to antibiotics administration [4,5]. Several variables, 
individually or together, have been taken into consideration as causes 
of CDI onset, but little was culled as really clarifying [6,7]. The aim 
of our study was to analyse clinical data and intestinal presences 
of cultivable microorganisms to assess if the certain risk factors 
are connected to the pathogen staying in human bowel or to the 
transition from spore to vegetative form, both necessary for the onset 
of the disease. We evaluated age, gender, provenance of patients and 
microbial composition of their stools according to the presence, in the 
same samples, of CD in both vegetative and spore forms.
Materials and Methods 
Patients and clinical specimens
From June 2011 to December 2012, unformed stools were collected 
from subjects affected by diarrhoea, i.e., 200 inpatients, admitted in San 
Martino University Hospital of Genoa, Italy, and 18 outpatients from 
the same regional area. All stools were sent to the Clinical Microbiology 
Laboratory of San Martino Hospital for detection of CD toxin B. We 
prospectively collected age, gender, communitarian or nosocomial 
provenance, and division of hospital admission. A single stool sample 
from each patient was included. The laboratory performed cultural, 
genomic, enzyme and automated immunoassay analyses of samples. 
The Institutional Ethics Committee of San Martino University Hospital 
approved the study (n. reg. CEA 13/11-Progetto ist Micro 1/2011), by 
dispending from informed consents.
Data collection and definitions 
Diarrhoea was defined as ≥ 3 unformed stools a day during at 
least two consecutive days. We included in the study stools samples 
definitely holding CD vegetative forms, i.e., those positive for tcdB gene 
and for both CD glutamate dehydrogenase (GDH) antigen and toxin 
B product, discarding those CD GDH positive and toxin B negative. 
We enrolled, as CD GDH/toxin B negative stools, only samples which 
negativity was confirmed through two different analytic methods. CD 
spores were assumed as present in samples tcdB gene positive and CD 
GDH/toxin B negative.
Detection of CD GDH and toxin B in stools
Diarrhoeic stools were initially analysed for the presence of CD 
GDH and toxin B with a Rapid Membrane Enzyme Immunoassay, 
C. diff Quik Chek Complete (Techlab Inc.) by 1 hour from arrival to 
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Abstract
Clostridium difficile infection in human occurs when the organism is present and germinating in the bowel. Old 
age of patients’ and particular microorganisms in stools are identified as risk factors for the disease onset. We aimed 
to investigate if risk factors for C. difficile infections in a large Italian hospital were connected to C. difficile intestinal 
presence or to germination. Toxin B positivity was linked with age over 65 years (P=0.03), medical hospitalization 
(P=0.015) and growth of Enterobacteriaceae (P=0.029) and Enterococcus (P=0.05) from the same stools. The 
presence of tcdB was even more strictly linked with old age (P=0.005), medicine hospitalization (P=0.012) and 
growth of Enterobacteriaceae (P=0.003) and Enterococcus (P=0.04). Our results indicated that the presence of C. 
difficile in stools, irrespective of being spore or vegetative form, is reliably associated with old age of subjects and 
fecal presence of viable Enterobacteriaceae and Enterococcus.
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laboratory. GDH/toxin B negative sample were analysed again with the 
more sensitive automated immunoassay VIDAS C. difficile GDH and 
VIDAS C. difficile Tox A/B [8].
Detection of tcdB gene in stools
Bacterial DNA was extracted from stools with the automated device 
QIAcube (QIAGEN). With DNA template, we performed Real-time 
polymerase chain reaction (RT-PCR) using RealCycler CDIF (Progenie 
Molecular), suitable to detect tcdB gene directly from stools, following 
manufacturer’s instructions. Faecal presence of tcdB indicated presence 
of toxigenic CD strains, as spores and vegetative forms.
Evaluation of microbial population of stools
Stools specimens were seeded and cultured on agar plates 
(Columbia, MacConkey, Mannitol Salt Agar, CHROMagar Candida 
- BBL) in O2 atmosphere, at 37°C for 24 hours, to value the growth 
of aerobic and best aerobic bacteria, including Enterobacteriaceae 
and Pseudomonadaceae families and Enterococcus and Staphylococcus 
genera, and the growth of yeasts, i.e., Candida genus. Colonies were 
identified through the growth on selective plates, microbiological tests, 
such as catalase, oxidase, bile-esculina agar [9] and, when needed, 
using matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS).
Thirty stools were also collected in tubes suitable for anaerobic 
culture (Vacutainer Anaerobic Specimen Collector, BBL), set on 
blood agar plates (BBL, Bacteroides bile esculin agar) and incubated 
at 37°C for 48 h in anaerobiosis, to allow Bacteroides fragilis group 
and Bacteroides fragilis strains, strictly anaerobic bacteria, to grow. 
We performed PCR analysis on DNA extracted from boiled anaerobic 
colonies. β-isopropylmalate dehydrogenase gene (leuB) and B. fragilis 
neuraminidase gene were amplified and revealed on gel electrophoresis 
for detecting, respectively, the presence of B. fragilis group and B. 
fragilis, as described elsewhere [10,11]. 
Statistical analysis
Results were expressed as mean ± standard deviation, the first and 
third quartile (1Q, 3Q), percentage, and odds ratio (OR) with their 95% 
confidence intervals (CI). Continuous variables were preliminarily 
evaluated for normal distribution with the Shapiro-Wilk test, and 
then compared by the non-parametric Wilcoxon-Mann-Whitney test. 
Categorical variables were compared with the Pearson chi-squared test. 
The main variables were evaluated by recursive partitioning. Following 
this approach, a conditional inference tree showing both the cut-points 
and the P-value of the associated independent test for each node was 
obtained [12]. Factors associated with presence of CD toxin B or cdtB 
gene in stools specimens were evaluated by logistic regression. The 
independent variables that reached statistical significance at univariate 
analysis were entered into multivariate regression models. Statistical 
significance was assumed with p-values <0.05 in two-tailed tests. 
Statistical analysis was performed using the R software/environment 
(version 3.1.2; R Foundation for Statistical Computing, Vienna, 
Austria).
Results
Clinical data, detection of CD GDH/toxin B and tcdB, and 
aerobic faecal microbiota
We enrolled 218 not consecutive patients, whose stools met 
requirements. Seventy-five subjects were ≤ 65 years and 143 were 
over. Out of total patients, 178 were lying in internal medicine wards 
and 22 in different types of division (11 in surgery and 11 in intensive 
care wards), whereas 18 were outpatients (Table 1). Fourth-two 
stools were CD GDH/toxin B positive and 176 negative. Most stools 
carried live aerobic bacteria of the genus Enterococcus (72.5%) and 
family Enterobacteriaceae (60.5%). Yeasts of the genus Candida and 
bacteria of the genus Staphylococcus and family Pseudomonaceae 
grown, respectively, from 42.7%, 32.1% and 7.8 of total stools (Table 
2). Amplification for tcdB gene was positive in 72 stools and negative 
in 146 (Table 3). Among 72 tcdB positive samples, 30 were negative for 
CD GDH/toxin B. 
Clinical data and intestinal microbial growth according to 
CD GDH/toxin B presence
CD GDH/toxin B positive stools were significantly more frequent 
than those negative among patients aged over 65 years (P=0.03) and 
subjects hospitalized in internal medicine wards (P=0.015) (Table 
1). Positive stools were more frequent than those negative also 
among subjects whose stools carried live Enterobacteriaceae and 
Pseudomonadaceae bacterial families (P=0.029, P=0.007) (Table 2). 
In specimens showing growth of Enterococcus, an almost significant 
frequency of CD GDH/toxin B positive specimens occurred (P=0.05), 
such as a prevalence, not reaching statistical significance, was among 
specimens showing growth of Candida and Staphylococcus genera. 
Candida colonies, present in the minor part of total specimens (42.7%), 
increased until the majority (52.4%) of those positive for CD GDH/
Demographic Characteristics Total n. Stools % GDH/toxinB Positive Stools %
GDH/toxin
B Negative Stools % P
#
Gender
female 122 56 19 45.2 103 58.5
male 96 44 23 54.8 73 41
Age
≤ 65 years 75 34.4 8 19 67 38
0.03
>65 years 143 65.6 34 81 109 61.9
Age, mean ± SD (1Q, 3Q) 73.21 ± 16.63 (68.5, 86) 67.60 ± 20.11 (53, 82)
Provenance
medicine 178 81.7 40 95.2 138 78.4
0.015




Table 1: Patients demographic data according to presence of Clostridium difficile GDH/toxin B in stools; #P value is indicated only when ≤ 0.05.
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toxin B (Table 2). Neither specific bacterial species nor the number of 
species identified differed between positive and negative groups (data 
not shown). 
Clinical data and intestinal microbial growth according to 
CD tcdB presence
By stratifying stool samples for presence and absence of tcdB, a 
significant difference was observed for both patients age over 65 years 
and mean age (P=0.005, P=0.043) (Table 3). A frequency significantly 
higher in patients tcdB positive than in negative was also found 
for hospitalization in internal medicine wards (P=0.012). Similar 
difference between tcdB positive and negative stools was observed 
for faecal presence of Enterobacteriaceae family and Enterococcus 
genus (P=0.003, P=0.04) (Table 4). The recursive partitioning analysis 
returned a conditional inference tree where in stool samples tcdB 
gene node (P=0.019) was associated with presence of Candida and 
Enterobacteriaceae in 34 patients (Figure 1). Neither specific bacterial 
species nor number of species differed after stratifying for presence and 
absence of tcdB gene (data not shown).
Logistic regression analysis for CD GDH/toxin B presence
In univariate logistic regression analysis performed for presence 
in stools of CD GDH/toxin B as dependent variable, statistical 
significance was found for age over 65 years (P=0.023), hospitalization 
in internal medicine wards (P=0.022), as well as for presence in stools 
of Enterobacteriaceae (P=0.024) and Pseudomonadaceae families 
(P=0.005), and Enterococcus (P=0.038). By entering these variables into 
a multivariate logistic regression model, only age over 65 years resulted 
no longer significant (Table 5). Although the multivariate model for 
CD GDH/toxin B presence revealed a high specificity (0.988), the 
sensitivity was very poor (0.095) (Figure 2A).
Logistic regression analysis for of CD tcdB presence 
In univariate logistic regression performed for presence in stools of 
tcdB gene as dependent variable, statistical significance was observed 
for age over 65 years (P=0.004), hospitalization in internal medicine 
wards (P=0.01), as well as for presence in stools of Enterobacteriaceae 
(P=0.002) and Enterococcus (P=0.03). These variables resulted 
statistically significant when entered into a multivariate logistic 
regression model (Table 6). The multivariate model for tcdB gene 
in stools revealed a balanced sensitivity (0.5) and specificity (0.842) 
(Figure 2B).
Clinical data and microbial growth according to CD GDH/
toxin B presence among tcdB positive specimens
We further compared frequency of old age, hospitalization in 
medical division and growth of best aerobic bacteria among the 
forty-two patients whose stools were positive for both tcdB gene and 
Organisms Grown in Stools Totaln. stools %
GDH/toxin B Positive 
Stools %
GDH/toxin B 
Negative Stools % P
#
Enterobacteriaceae y* 132 60.5 32 76.2 100 56.8
0.029
Enterobacteriaceae n** 86 39 10 23.8 76 43.2
Enterococcus y 158 72.5 36 85.7 122 69.3
0.05
Enterococcus n 60 27.5 6 14 54 30.7
Candida y 93 42.7 22 52.4 71 40.3
Candida n 125 57.3 20 47.6 105 59.7
Staphylococcus y 70 32.1 16 38.1 54 30.7
Staphylococcus n 148 67.9 26 61.9 122 69.3
Pseudomonadaceae y 17 7.8 8 19.1 9 5.1
0.007
Pseudomonadaceae n 201 92.2 34 80.9 167 94.9
Table 2: Microbial fecal growth according to presence of Clostridium difficile GDH/toxin B in stools; *microbial family or genus grown from stool specimens; **microbial 








Negative Stools % P
#
Gender
female 122 56 40 55.6 82 56.2
male 96 44 32 44.4 64 43.8
Age
≤ 65 years 75 34.4 15 20.8 60 41.1
0.005
> 65 years 143 65.6 57 79.2 86 58.9
Age, mean ± SD
(1Q, 3Q) 73.29 ± 18.87 (68, 87) 66.90 ± 19.74 (52.25, 81) 0.043
Provenance
medicine 178 81.7 66 91.7 112 76.7
0.012




Table 3: Patients demographic data according to presence of Clostridium difficile tcdB gene in stools; #P value is indicated only when ≤ 0.05.
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CD GDH/toxin B and among the thirty patients whose stools were 
positive for tcdB gene and negative for GDH/toxin B. The remarkable 
correlation found between GDH/toxin B and tcdB positivity and age 
greatly decreased, losing statistical significance. The correlation between 
GDH/toxin B and tcdB positivity and provenance of patients lost 
relevance. The connection with growth of best aerobic microorganisms 
totally disappeared, and, when we analysed thirty samples collected in 
tube suitable for anaerobic culture to detect viable B. fragilis group and 
B. fragilis strains, we did not find any difference between positive and 
negative groups (data not shown). 
Discussion
The development of CDI in humans depends on two essential 
events, i.e., the pathogen presence in the gut and its germination, which 
lead to the production of bacterial toxins [13]. The occurrence of two 
different basic factors in CDI pathogenesis has made the understanding 
more difficult than that of most bacterial infections, and complicated 
over time the diagnosis and the related epidemiology [2,14]. 
Numerous investigations clearly demonstrated that intestinal biota, 
now called microbiota, has vital roles in maintaining the physiology 
of bowel, and that modifications, physiological or therapeutic, are 
fundamental in CDI onset [15,16]. Advanced age of patients is often 
characterized by changes of microbiota and is definitely associated 
with CDI [17]. We focused on a few variables that represent risk 
factors, to separate and quantify the relative influence they have on 
CD intestinal presence and on the germination process. We did not 
consider the exposure to antibiotics, but only some features of bowel 
biota, because it is ascertained that CDI onset can be independent from 
drug administration, though to a lesser part. In addition, it is now clear 
that, when CDI onset depends on antibiotics, the link is represented 
by modification of intestinal biota and, when not, the microbiota of 
affected subjects is different from that of healthy people [14]. 
We assessed demographic and microbiological data according 
to faecal presence-absence of CD GDH/toxin B and the codifying 
gene, cdtB. We found a strong connection between CD GDH/toxin B 
presence and age of patients over 65 years, and between the same toxin 
positivity and the growth of organisms of family Enterobacteriaceae 
and genus Enterococcus from the samples. These bacterial groups 
have emerged as frequently linked to CDI from studies conducted on 
mice and humans through molecular methods [4,15,16]. We found 
interesting, although statistically not significant, data on intestinal 
presence of yeasts of genus Candida, which, identified to a lesser extent 
among total stools, grew from most part of those positive for CD GDH/
toxin B. The intestinal presence of CD toxin B appeared to be connected 
to a general presence of aerobic microbial families and genera. The lack 
of species specificity is reflected in previous studies where microbial 
modifications due to antibiotic therapies, and connected to CDI, 
though dissimilar among different reports, led to a same change in 
function [18-20]. These differences allowed the metabolic hypothesis 
to replace that structural, based on alleged lowering of microbiota in 
toto and on diminished competition for nutrients and ecological niches 
[21,22]. Given the different functional and metabolic characteristics of 
aerobic and anaerobic microorganisms, and a possible different role in 
CDI onset, we separately examined their growth. We chose culture-
based methods to detect live microorganisms and to exclude those 
stopped in growth by any effective antibiotic therapy.
When we compared the faecal presence of GDH/toxin B with the 
provenance of samples, we found a strong connection between CDI 
and staying of patients in medical wards, which contradicts those 
works where surgery wards or intensive care units stand out among 
risk factors for the disease [23]. Interestingly, the connection of old age, 
faecal presence of aerobic microorganisms and medical admission with 
the mere presence of CD in the stools appeared more significant than 
the connection with the presence of GDH/toxin B. In particular, age 
over 65 years emerged as really determinant also in multivariate logistic 
regression only when we compared for tcdB presence. This aspect 
suggests that significance of old age in relation to toxin production 
could be misleading, i.e., due just to the presence of the microorganism 
in the bowel of patients.
As other authors, we thought that the changes in microbial 
community and in metabolic environment would allow germination 
Figure 1: The best conditional inference tree returned by the recursive 
partitioning analysis, with both the cut-points and the p-value of the associated 
independent test for each node (Candida, Staphylococcus, cdtB gene). The 
columns are referred to the presence/absence (Yes/No) of Enterobacteriaceae 
in stool specimens.
Figure 2: (A) Multivariate logistic regression model for C. difficile toxin B in 
stools (independent variables: age over 65 years; hospitalization in internal 
medicine wards; presence in stools of Enterobacteriaceae, Enterococcus, 
and Pseudomonadaceae). (B) Multivariate logistic regression model for 
the presence of cdtB gene in stools (independent variables: age over 65 
years; hospitalization in internal medicine wards; presence in stools of 
Enterobacteriaceae and Enterococcus).
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Negative Stools % P
#
Enterobacteriaceae y* 132 60.5 54 75 78 53.4
0.003
Enterobacteriaceae n** 86 39 18 25 68 46.6
Enterococcus y 158 72.5 59 81.9 99 67.8
0.04
Enterococcus n 60 27.5 13 18 54 32.2
Candida y 93 42.7 34 47.2 59 40.4
Candida n 125 57.3 38 52.8 87 59.6
Staphylococcus y 70 32.1 24 33.3 46 31.5
Staphylococcus n 148 67.9 48 66.7 100 68.5
Pseudomonadaceae y 17 7.8 8 11.1 9 6.2
Ppeudomonadaceae n 201 92.2 64 88.9 137 93.8
Table 4: Microbial fecal growth according to presence of Clostridium difficile tcdB gene in stools; * microbial family or genus grown from stool specimens; ** microbial family 
or genus not grown from stool specimens; # P value is indicated only when ≤ 0.05.
Clostridium difficile GDH/toxinB
Univariate Multivariate
OR (95% CI) P OR (95% CI) P
Gender, male 1.708 (0.868-3.392) 0.121
Age 1.016 (0.997-1.037) 0.097
Age > 65 years 2.612 (1.192-6.371) 0.023 2.095 (0.903-5.329) 0.098
Provenance, internal medicine 5.507 (1.588-34.763) 0.022 5.572 (1.516-36.475) 0.026
Presence in stools of
Enterobacteriaceae 2.432 (1.160-5.495) 0.024 2.724 (1.228-6.528) 0.018
Enterococcus 2.655 (1.126-7.337) 0.038 2.717 (1.079-7.952) 0.046
Candida 1.626 (0.826-3.129) 0.158
Staphylococcus 1.390 (0.679-2.780) 0.356
Pseudomonadaceae 4.366 (1.539-12.231) 0.005 4.852 (1.571-15.235) 0.005
Table 5: Univariate and multivariate analysis of factors associated with presence of Clostridium difficile GDH/toxin B in stool specimens.
Clostridium difficile tcdB gene
Univariate Multivariate
OR (95% CI) P OR (95% CI) P
Gender, male 1.025 (0.578-1.808) 0.932
Age 1.015 (0.999-1.031) 0.058
Age>65 years 2.651 (1.400-5.254) 0.004 2.342 (1.196-4.770) 0.015
Provenance, internal medicine 3.339 (1.419-9.210) 0.010 3.454 (1.423-9.761) 0.010
Presence in stools of
Enterobacteriaceae 2.615 (1.420-4.982) 0.002 2.766 (1.453-5.445) 0.002
Enterococcus 2.154 (1.101-4.451) 0.030 2.125 (1.036-4.756) 0.045
Candida 1.319 (0.746-2.332) 0.339
Staphylococcus 1.087 (0.590-1.974) 0.786
Pseudomonadaceae 1.902 (0.685-5.201) 0.206
Table 6: Univariate and multivariate analysis of factors associated with presence of Clostridium difficile tcdB gene in stool specimens.
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from resting to vegetative morphotype of CD. To understand the 
causes of shift, many cross-sectional studies compared samples from 
patients affected by CDI with those from healthy and patients affected 
by non-CDI diarrhoea [24]. The lack of prospective human samples 
collected both before and after CDI left the underlying cause of disease 
unknown [16]. Here, we compared subjects as similar as possible, 
namely, ascertained patients carrying CD vegetative forms and patients 
carrying CD spores, whose diarrhoea was due to different reasons. In 
this contest, the relevance of old age, presence of best aerobic bacteria 
and medical admission totally disappeared. Not even the intestinal 
absence of Bacteroides, bacteria susceptible to antibiotics involved in 
CDI and able to inhibit the germination process appeared as favourable 
condition for spore germination [4,25,26]. The lack of results from 
the presence of Bacteroides could be due to a limitation of our study, 
i.e., the small number of stools obtained in suitable tubes. The lack of 
other correlations displaying the why of germination is likely due to 
the complexity of the subtle microbial homeostasis of human bowel. 
This complexity is proved by the fact that the only success in recurrent 
CDIs was obtained with faecal microbiota transplantation (FMT) [27]. 
Indeed, when FMT is efficient to recover the colonization resistance 
of faecal community, its composition remains different from the pre-
infection status, leaving the microbiome signatures that correlate with 
protection unidentified [28,29].
Finally, further investigations are necessary to discover those 
factors that protect against germination of CD. However, the void of 
microbiological indications concerning the process of germination 
may hint interesting reconsiderations on the true meaning of data 
concerning the simple intestinal presence of CD. In fact, since the onset 
of CDI is the sum of intestinal presence and germination of CD, the less 
is the influence of risk factors on germination process, the greater is the 
influence on intestinal presence of the microorganism itself. We also 
suppose that the connection of CDI with admission of patients into 
medical wards could be due to the dietary intake of CD, instead limited 
in intensive care wards and in surgery divisions. Moreover, in analogy 
with what recently demonstrated in a murine model, where FMT has 
led to the clearance of CD [30], the composition of faecal microbiota of 
elderly patients would provide a metabolic environment favourable for 
durable permanence of the organism in their gut.
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